CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies

Laura Martinez‐Verbo; Lorea Villanueva; Pere Llinàs‐Arias; Carlos A. García‐Prieto; David Piñeyro; Aina Oliver‐Cáldes; Almudena García-Ortiz; Antonio Valeri; Carlos Fernández de Larrea; Joaquín Martínez‐López; Gerardo Ferrer; Manel Esteller

doi:10.1182/blood-2023-179313

Related publications

Article2023

P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES

Laura Martinez‐Verbo, Lorea Villanueva, Pere Llinàs‐Arias, Carlos A. García‐Prieto, David Piñeyro, Aina Oliver‐Cáldes, Almudena García-Ortiz, Antonio Valeri, Carlos Fernández de Larrea, Joaquín Martínez‐López, Gerardo Ferrer, Manel Esteller

Article2025

Impact of immunoglobulin supplementation on infection rates in myeloma patients receiving novel immunotherapies

Efstathios Kastritis, Eirini Solia, Ilias Katsadouros, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, Foteini Theodorakakou, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Magdalini Migkou, Vasiliki Spiliopoulou, Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos

Article2020

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

Roberto Mina, Nisha S. Joseph, Francesca Gay, Efstathios Kastritis, Maria Teresa Petrucci, Jonathan L. Kaufman, Vittorio Montefusco, Maria Gavriatopoulou, Francesca Patriarca, Paola Omedè, Lawrence Boise, Μαρία Ρούσσου, Nicola Giuliani, Stefania Oliva, Massimo Offidani, Angelo Belotti, David L. Jaye, Lorenzo De Paoli, Evangelos Terpos, Sagar Lonial, Mario Boccadoro, Ajay K. Nooka, Meletios A Dimopoulos

Article2007

The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma

Evangelos Terpos, Meletios A Dimopoulos, Orhan Sezer

Article2015

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis, Sossana Delimpasis, Argiris Symeonidis, Panagiotis Repousis, Marie‐Christine Kyrtsonis, Chrysa Vadikolia, Eurydiki Michalis, Genovefa Polychronidou, Michalis Michael, Sofia Papadaki, Μαρία Παπαθανασίου, Kyriaki Kokoviadou, Anna Kioumi, Efthymia Vlachaki, Christina Hadjiaggelidou, Alexandra Kouraklis, Ioannis Patsias, Maria Gavriatopoulou, Maria Kotsopoulou,